13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001104659-25-049396
Total Value
$87.6M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Alumis Inc | ALMS | 5,779,348 | $35.5M | 40.50% |
| 2 | CG Oncology, Inc. | CGON | 859,050 | $21.0M | 24.01% |
| 3 | Disc Medicine, Inc. | IRON | 299,069 | $14.8M | 16.94% |
| 4 | Hims & Hers Health, Inc. | HIMS | 273,151 | $8.1M | 9.21% |
| 5 | Lyell Immunopharma Inc | LYEL | 8,133,047 | $4.4M | 4.99% |
| 6 | Maze Therapeutics Inc | MAZE | 345,191 | $3.8M | 4.34% |